Navigation Links
Identification of 'fingerprint' of rare tumor leads to development of cheap and reliable new test
Date:5/19/2011

Researchers at the University of Oxford have developed a cheap and reliable diagnostic test for a rare form of cancer. The test involves screening tumour samples for a particular molecular fingerprint unique to this type of cancer.

Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a disorder which causes the development of benign but often painful tumours in the skin and, in females, in the uterus. Between one in six and one in ten people affected by the disorder will go on to develop an aggressive form of kidney cancer called papillary renal cell cancer. The condition often strikes people in their twenties.

The disorder is caused by mutations, which may be inherited, in a gene responsible for the production of an enzyme known as fumarate hydratase (FH). This leads to an accumulation within cells of fumarate, which promotes the development of cancer cells.

Now, in a study published in The Journal of Pathology, an international team of scientists led by researchers at the Henry Wellcome Building for Molecular Physiology, University of Oxford, have identified a particular protein modification which is induced by FH deficiency (and hence an over-abundance of fumarate). This alteration is unique to this type of tumour and can hence be used as a biomarker a biological 'fingerprint' to identify tumours caused by this mechanism.

The researchers have developed a test for this protein modification which can be carried out in less than two hours and will identify tumours with FH mutations. This approach is much more cost effective than genetic testing of all possible cases using DNA sequencing. They show that screening cases of papillary renal cell cancer using this new test allows them to identify undiagnosed cases of HLRCC for genetic testing. They believe this test should be applied to all cases of papillary renal cell cancer to identify those with FH mutations, allowing advice to be provided to their families on
'/>"/>

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New UC Davis study finds early Alzheimers identification method
2. New VKernel AppVIEW 1.0 for Monitoring and Identification of Capacity Bottlenecks in Critical Application VMs
3. Most Breast Tumors Have Unique Genetic Fingerprint, Study Finds
4. New diagnostic chip able to generate single-cell molecular fingerprints for brain tumors
5. Scientists Spot Genetic Fingerprints of Individual Cancers
6. Recurring cancers in women with a history of breast cancer differ from the original tumors
7. Mayo Clinic finds surgeon caseload, practice setting affect treatment of small kidney tumors
8. Brain Surgery for Mary Tyler Moore to Remove Benign Tumor
9. Stanford discoveries about tumor-suppressing protein could help to reduce treatment side effects
10. Scientists use genetically altered virus to get tumors to tattle on themselves
11. Strong evidence supports prognostic value of circulating tumor cells in breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 30, 2015 , ... Macro Wealth Management ... through the Smile for a Lifetime program by encouraging their clients to donate their ... by MWM Presidents Dr. Mart McClellan and Tim Streid, who see charitable giving as ...
(Date:7/29/2015)... ... July 30, 2015 , ... In their continuing drive ... of online continuing education courses for Athletic Trainers , HomeCEUConnection.com, today announced ... and Education Sports Medicine Series. , The new online continuing education courses were ...
(Date:7/29/2015)... ... July 29, 2015 , ... If you’re a fan of Vietnamese banh mi ... by the Orange County Register , more than 465,000 pounds of mislabeled meat ... article does not mention any reported illnesses that have been connected to problems reportedly ...
(Date:7/29/2015)... ... 2015 , ... Sports fans young and old at the National Cherry Festival ... Detroit Lions, joined by A Forever Recovery, a holistic treatment center for substance abuse ... Pro Bowl Offensive Lineman Lomas Brown, and Tight End Rob Rubick signed foam footballs, ...
(Date:7/29/2015)... ... July 29, 2015 , ... Conventional theories used by economists for the ... may be able to unlock mysteries about the behavior of microbial life on earth, ... and Columbia University. , The findings, published July 29 in the open access journal ...
Breaking Medicine News(10 mins):Health News:Smile for a Lifetime (S4L) Partners with Macro Wealth Management (MWM) Helping More Children Get Braces 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 2Health News:Three Important Product Liability Realities Offered In Light of News of Recent Product Recalls 3Health News:A Forever Recovery Holds Autograph Event with Former Detroit Lions at Cherry Festival 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 2Health News:University Researchers Apply Economic Concepts to Explore the Mysteries of the Microbial World 3
... the most feared diseases all around the world. Researchers ... offering adult diabetics an alternative to injections// for controlling ... approved by the FDA. ,If approved, the drug, ... insulin injections taken by millions worldwide. The product works ...
... the study show that increasing intake of the common flavouring ... dieters eat less and reduce cravings brought on by sugar ... of vinegar consumed by 12 healthy subjects and their glucose ... the study, volunteers were given three amounts of vinegar (18, ...
... weight for health, it is equally important to lose weight ... of fruits, vegetables, whole grains and other such nutritious foods// ... and follow and is more effective than the conventional diet ... ,A low-fat, plant-based diet has been found to be ...
... Conventional therapy for this for of cancer is to remove ... liver. Survival for patients// with this type of operation is ... treated this way because the tumors can involve both sides ... tumor that is often found in the lining of the ...
... world is like a stage “, written by William Shakespeare ... read, nice to listen but a little difficult to accept ... given to aging, very little is done to understand the ... would have been embarrassed by the odd behavior of old ...
... 25% of the MRSA infections in the hospital happen in ... The research was published in the latest issue of BMJ// ... serious form of infection is that in which blood stream ... bacteremia by hospital trust, but it has not yet addressed ...
Cached Medicine News:Health News:Exubera could mean the end of an insulin injection era for diabetics 2Health News:Weight loss accomplished by high carbohydrate, vegan diet 2Health News:Combined modality approach for effective treatment and enhanced survival in bile duct cancer 2Health News:Do not regret growing older, It is a privilege denied to many 2
(Date:7/29/2015)... 29, 2015 Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, today announced that it will release ... 10, 2015 after the close of the U.S. financial ... webcast on Monday, August 10, 2015 at 4:30 p.m. ... and corporate developments. For both "listen-only" participants ...
(Date:7/29/2015)... 29, 2015  Depomed, Inc. (NASDAQ: DEPO ) ... Board of Directors, after careful consideration and with ... advisors, has unanimously rejected the purported revised, highly ... plc (NASDAQ: HZNP ) ("Horizon") to acquire ... an all-stock transaction (the "July 21 Proposal"). ...
(Date:7/29/2015)... 29, 2015 Immune Pharmaceuticals Inc. (NASDAQ: IMNP ... up to $21.5 million through two financing agreements. The ... ) ("Hercules"), for a term loan of up to ... Growth Fund ("Discover"), for the sale to Discover of ... Stock") for up to $12 million in gross proceeds ...
Breaking Medicine Technology:Asterias Biotherapeutics to Report Second Quarter Results on August 10, 2015 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7
... Medical, Inc. (NASDAQ: ICUI ) today announced ... 36th annual meeting of the California Society of Health-System ... company,s ChemoClave® closed system transfer device (CSTD) designed to ... to hazardous drugs is more affordable for hospitals to ...
... FRANCISCO and RIDGEFIELD, Conn., Nov. 8, 2011  Boehringer ... Phase 2 studies evaluating the combination of the company,s ... ribavirin (RBV) in treatment-naive genotype-1 (GT1) hepatitis C virus ... SILEN-C1 studies show that BI 201335 may have ...
Cached Medicine Technology:Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 2Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 3Breaking Study: ICU Medical, Inc. ChemoClave® System Costs Less to Implement than any Closed System Transfer Device for the Safe Handling of Hazardous Drugs 4Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 2Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 3Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 4Sustained Viral Response from Phase 2 Studies of BI 201335, Including Difficult-to-Treat HCV Patient Types 5
... The Finnpipette BioControl ... innovative features as the ... universal handle fits all ... single channel tip cone ...
... Easy to Use , The new Finnpipette ... use it in only a few minutes. With the ... can choose all the pipetting functions you need quickly ... read and shows the full names of all functions. ...
... a 384 Well Plate at Once , To ... you need a pipettor that can adapt to ... get with our 16-channel Impact pipettor., Available with ... was specifically designed to allow you to transfer ...
... CS and Alliance Catheter Delivery ... the introduction of catheters or ... from a superior approach. These ... outstanding peel-away introducer performance with ...
Medicine Products: